FDI in 2021: M&A trends
The number of cross-border merger and acquisition (M&A) announcements increased significantly in 2021 with a 45.2% jump compared to the…
Deals Analysis
These were the biggest pharmaceutical deals in early 2022
Top and emerging locations for M&A deals in the pharmaceutical industry
Inside Philip Morris’ controversial Vectura acquisition
Science park merger creates UK’s largest life sciences ecosystem
AZ’s proposed acquisition of rare disease-focused Alexion gets US clearance
Exscientia raises $100m Series C funding to develop fully autonomous drug design
SIRION and Sanofi partner on next-gen AAV gene therapy vectors
